Abstract
Little is known about cardiac uptake kinetics of idarubicin, including a possible protective role of P-glycoprotein (Pgp)-mediated transport. This study therefore investigated uptake and negative inotropic action of idarubicin in the single-pass isolated perfused rat heart by using a pharmacokinetic/pharmacodynamic modeling approach. Idarubicin was administered as a 10-min constant infusion of 0.5 mg followed by a 70-min washout period in the absence and presence of the Pgp antagonists verapamil or amiodarone. Outflow concentration and left ventricular developed pressure were measured and the model parameters were estimated by simultaneous nonlinear regression. The results indicate the existence of a saturable, Michaelis-Menten type uptake process into the heart (Km = 3.06 μM,Vmax = 46.0 μM/min). Verapamil and amiodarone significantly enhanced the influx rate (Vmax increased 1.8-fold), suggesting that idarubicin is transported by Pgp directly out of the membrane before it gets into the cell. Verapamil and amiodarone attenuated the negative inotropic action of idarubicin, which was linked to the intracellular concentration of idarubicin.
Footnotes
-
This work was partially supported by Deutsche Forschungsgemeinschaft (GRK 134/1-96).
- Abbreviations:
- MDR
- multiple drug resistance
- Pgp
- P-glycoprotein
- IDA
- idarubicin
- LVDP
- left ventricular developed pressure
- SNLR
- simultaneous nonlinear regression
- CV
- coefficient of variation of parameter estimate
- Received August 29, 2001.
- Accepted November 2, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|